Executives
The most important part of any company is its team. The Lions Capital team is built around a core of very successful entrepreneurs and early-stage investors. Several of them have been instrumental in a number of successful BC technology and life sciences companies.
 |
Dr. Rix is the founder and Chairman of MDS Metro Laboratory Services, which was sold to OMERS for $1.4 billion in 2007. Dr. Rix received the Order of Canada in 2007 for his contributions to the life science industry.
Read full bio » |
| |
|
 |
Frank Holler is an active investor and successful entrepreneur. He previously served as President & CEO of Xenon Pharmaceuticals Inc.; President & CEO of ID Biomedical Corporation; and as a founding director of Angiotech Pharmaceuticals.
Read full bio » |
| |
|
 |
Jim Heppell has acted as a director or officer of, or advisor to, approximately one third of all life science companies spun out of BC universities. He is a co-founder and Fund Manager of the Advantage Life Science Fund I, the best performing retail fund in Canada over the last five years.
Read full bio » |
| |
|
 |
David Raffa is the former Chairman of ActiveState Corporation and co-founder of Amorfix Life Sciences. He is a mergers and acquisitions specialist.
Read full bio » |
| |
|
 |
Tanner Philp is a director or officer of, or advisor to, early stage technology companies with experience in financings and mergers and acquisitions and is also the recipient of the 2007 BC Chartered Accountant Early achievement Award.
Read full bio » |
| |
|
 |
Ray Matthews leads Advantage's fund raising efforts. He was co-founder of the Advantage Life Science Fund I, the best performing retain fund in Canada over the last five years.
Read full bio » |
|
